As Head of Process Development at Mabion, Anna leads efforts to innovate and optimize biologics manufacturing. Her role bridges scientific insight and strategic execution, ensuring robust processes from early development to commercial scale. Anna holds a PhD in biochemistry and brings extensive experience in both academic research and pharmaceutical production. Her work supports the delivery of high-quality biologics through streamlined, compliant process design.
